Induction of indoleamine 2,3-dioxygenase expression via heme oxygenase-1-dependant pathway during murine dendritic cell maturation
- Authors
- Jung, In Duk; Lee, Jun Sik; Lee, Chang-Min; Noh, Kyung Tae; Jeong, Yeong-Il; Park, Won Sun; Chun, Sung Hak; Jeong, Soo Kyung; Park, Jin Wook; Son, Kwang Hee; Heo, Deok Rim; Lee, Min-Goo; Shin, Yong Kyoo; Kim, Han Wool; Yun, Cheol-Heui; Park, Yeong-Min
- Issue Date
- 15-8월-2010
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Keywords
- Dendritic cells; Heme oxygenase; Indoleamine 2,3-dioxygenase; Lipopolysaccharide
- Citation
- BIOCHEMICAL PHARMACOLOGY, v.80, no.4, pp.491 - 505
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOCHEMICAL PHARMACOLOGY
- Volume
- 80
- Number
- 4
- Start Page
- 491
- End Page
- 505
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/115878
- DOI
- 10.1016/j.bcp.2010.04.025
- ISSN
- 0006-2952
- Abstract
- Heme oxygenase (HO)-1 is expressed in a variety of conditions involved in the regulation of immune responses. In this study, we examined the role of HO-1 in dendritic cell (DC) maturation and expression of indoleamine 2,3-dioxygenase (IDO), a key enzyme that catalyzes the initial, rate-limiting step in tryptophan degradation. IDO deficiency led to diminished phenotypic and functional maturation of DCs in vitro and in vivo. IDO expression and DC maturation was abrogated by the HO inhibitor zinc protoporphrin, but increased by hemin, a potent inducer of HO-1. Moreover, LPS-induced HO-1 expression was mediated by an NF-kappa B-dependent pathway. Our findings provide additional insight into the immunological functions of IDO and HO-1, and suggest possible therapeutic adjuvants for the treatment of DC-related acute and chronic diseases. (C) 2010 Elsevier Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.